Dr. Bouberhan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Boston, MA 02114
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 2012 - 2015
University of Virginia School of MedicineClass of 2012
Certifications & Licensure
MA State Medical License 2016 - 2026
CT State Medical License 2015 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression Start of enrollment: 2020 Jul 23
- Genetic Testing Decision Aid Start of enrollment: 2022 Oct 14
Roles: Contact, Principal Investigator
- IMGN853 With Carboplatin in Second-line Treatment of FRα Expressing, Platinum-sensitive Epithelial Ovarian Cancer Start of enrollment: 2022 Sep 28
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Population pharmacokinetics and exposure-response relationships of dostarlimab in primary advanced or recurrent endometrial cancer in part 1 of RUBY.Mita Kuchimanchi, Trine Lembrecht Jørgensen, Eva Hanze, Thierry André, Angela Jain
British Journal of Clinical Pharmacology. 2024-11-08 - 3 citationsKidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors.Shruti Gupta, Paul E Hanna, Tianqi Ouyang, Karla Sofia Yamada, Rani Sawtell
Journal of the National Cancer Institute. 2023-07-06 - 51 citationsSystematic identification of anticancer drug targets reveals a nucleus-to-mitochondria ROS-sensing pathway.Junbing Zhang, Claire M Simpson, Jacqueline Berner, Harrison B Chong, Jiafeng Fang
Cell. 2023-05-25
Press Mentions
Financial Toxicity Associated with Cancer Care Impacts Nearly 50% of Women with Gynecologic Cancer and Disproportionately AffectsJune 11th, 2021- The Power of Shared Purpose: Transforming Gynecologic Cancer CareMarch 26th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
